FC
Foresite Capital Fund VI LP disclosed a 6% stake in IRLA
Foresite Capital Fund VI LP reported owning 6% of IRulya Therapeutics Inc. (IRLA) (652,039 shares) in a Schedule 13G filed Oct 14, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 14, 2026
- Source
- Schedule 13G